Largest Clinical Trials companies in Sweden by Market Capitalization
Sweden
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.58 B |
Jan. 14, 2025 | USD 17.87 | 3.09% |
|
Sweden |
|
| 2 |
USD 190.69 M |
Jan. 14, 2025 | USD 2.91 | -2.20% |
|
Sweden |
|
| 3 |
USD 180.59 M |
Jan. 14, 2025 | USD 2.74 | 1.67% |
|
Sweden |
|
| 4 |
USD 167.86 M |
Jan. 14, 2025 | USD 1.61 | 0.34% |
|
Sweden |
|
| 5 |
USD 46.91 M |
Jan. 14, 2025 | USD 0.90 | 9.88% |
|
Sweden |
|
| 6 |
USD 35.90 M |
Jan. 14, 2025 | USD 0.71 | -2.02% |
|
Sweden |
|
| 7 |
USD 32.52 M |
Jan. 14, 2025 | USD 0.20 | 1.12% |
|
Sweden |
|
| 8 |
USD 24.76 M |
Jan. 14, 2025 | USD 1.17 | -3.73% |
|
Sweden |
|
| 9 |
USD 20.51 M |
Jan. 14, 2025 | USD 0.84 | -0.17% |
|
Sweden |
|
| 10 |
USD 15.76 M |
Jan. 14, 2025 | USD 0.22 | -6.29% |
|
Sweden |
|
| 11 |
USD 12.09 M |
Jan. 14, 2025 | USD 0.10 | 0.68% |
|
Sweden |
|
| 12 |
USD 10.71 M |
Jan. 14, 2025 | USD 0.39 | 2.53% |
|
Sweden |
|
| 13 |
USD 8.04 M |
Jan. 14, 2025 | USD 0.23 | 11.53% |
|
Sweden |
|
| 14 |
USD 5.61 M |
Jan. 14, 2025 | USD 0.28 | -7.61% |
|
Sweden |
|
| 15 |
USD 5.48 M |
Jan. 14, 2025 | USD 0.80 | 0.68% |
|
Sweden |
|
| 16 |
USD 5.22 M |
Jan. 14, 2025 | USD 0.45 | 23.08% |
|
Sweden |
|
| 17 |
USD 4.23 M |
Jan. 14, 2025 | USD 0.21 | 0.68% |
|
Sweden |
|
| 18 |
USD 1.35 M |
Jan. 14, 2025 | USD 0.11 | 1.51% |
|
Sweden |
Frequently Asked Questions
-
Which Clinical Trials company in Sweden has the highest Market Capitalization ?
The Clinical Trials company in Sweden with the highest Market Capitalization is BioArctic AB (publ) (Stockholm Stock Exchange: BIOA-B.ST) at USD 1.58 B.
-
Which Clinical Trials company in Sweden has the lowest Market Capitalization ?
The Clinical Trials company in Sweden with the lowest Market Capitalization is Aptahem AB (publ) (Stockholm Stock Exchange: APTA.ST) at USD 1.35 M.
-
What are the top 10 Clinical Trials companies in Sweden by Market Capitalization ?
The top 10 Clinical Trials companies in Sweden by Market Capitalization are BioArctic AB (publ), Hansa Biopharma AB (publ), BioInvent International AB (publ), Diamyd Medical AB (publ), IRLAB Therapeutics AB (publ), Mendus AB (publ), Isofol Medical AB (publ), Lipum AB (publ), Corline Biomedical AB and NextCell Pharma AB.
-
What are the bottom 10 Clinical Trials companies in Sweden by Market Capitalization ?
The bottom 10 Clinical Trials companies in Sweden by Market Capitalization are Aptahem AB (publ), CombiGene AB (publ), OncoZenge AB (publ), Prostatype Genomics AB (publ), Clinical Laserthermia Systems AB (publ), Elicera Therapeutics AB (publ), Pila Pharma AB (publ), Kancera AB (publ), NextCell Pharma AB and Corline Biomedical AB.